Biotech Frontiers

Life-science and biotech investing is our focus in Biotech Frontiers… Some startups follow a clear, smooth path to success. Others skyrocket, then quickly fall back to Earth. But, generally speaking, as a sector, biotech stocks perform differently than tech stocks, “forever stocks,” and certainly the blue chips… Biotech veteran Erez Kalir heads up this advisory that publishes on the first Thursday of each month, with regular unscheduled updates as they are needed.

Issues & Updates


  • Marty Fridson’s Stock-Picking Formula
    In this issue of Saturday Stock Screen... we use a filter developed by Marty Fridson to sift through thousands of stocks to find a handful that we will then do more in-depth analysis for possible inclusion in our Complete Investor or our other portfolios.
  • Complete Investor Roundtable – December 2025
    Go inside the Complete Investor Roundtable as Porter and the full editorial team decide what belongs in the portfolio… and what doesn’t. In the editorial discussion, you’ll see how our analysts challenge each other’s assumptions, stress-test ideas, and debate what deserves a coveted spot in our Best Buys. In this new Roundtable feature – filmed monthly – Porter and the
  • Complete Investor Roundtable – November 2025
    Go inside the Complete Investor “war room” as Porter and the full editorial team pull back the curtain on how to decide what belongs in the portfolio. In the editorial roundtable, you’ll see how our analysts challenge each other’s assumptions, stress-test ideas, and debate what deserves a coveted spot in our Best Buys. From classic consumer franchises
  • Finishing Up Our Grading For 2025
    Today, Porter completes the report-card grading of the Porter & Co. financial publications with the final three of our remaining advisories – Porter & Co.’s Asymmetry, The Trading Club, and Porter’s Permanent Portfolio.


Special Reports

America’s Last Election